Information  X 
Enter a valid email address

Premaitha Health revenue up 45% in first half

By BFN News | 07:34 AM | Friday 12 October, 2018


Molecular diagnostics group Premaitha Health said its revenue in the first half grew by 45% to around £3.9m. Premaitha also said it had made a 'strong start' to the second half. All required legal settlement actions relating to patent infringement court proceedings had now been completed, it added. 'I am pleased to report strong sales growth in the first half of the financial year and that this momentum has continued into the second half,' chief executive Lyn Rees said. 'With the intellectual property litigation now behind us, the company is focused on capitalising on its global opportunity and driving growth.' Story provided by StockMarketWire.com

a d v e r t i s e m e n t